19-5914639-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_004058.5(CAPS):c.160G>A(p.Gly54Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0015 in 1,614,014 control chromosomes in the GnomAD database, including 40 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.0016 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0015 ( 38 hom. )
Consequence
CAPS
NM_004058.5 missense
NM_004058.5 missense
Scores
3
8
4
Clinical Significance
Conservation
PhyloP100: 4.68
Genes affected
CAPS (HGNC:1487): (calcyphosine) This gene encodes a calcium-binding protein, which may play a role in the regulation of ion transport. A similar protein was first described as a potentially important regulatory protein in the dog thyroid and was termed as R2D5 antigen in rabbit. Alternative splicing of this gene generates two transcript variants. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.010447592).
BP6
Variant 19-5914639-G-A is Benign according to our data. Variant chr19-5914639-G-A is described in ClinVar as [Benign]. Clinvar id is 3043545.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population sas. gnomad4_exome allele frequency = 0.00149 (2180/1461660) while in subpopulation SAS AF= 0.02 (1727/86250). AF 95% confidence interval is 0.0192. There are 38 homozygotes in gnomad4_exome. There are 1485 alleles in male gnomad4_exome subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CAPS | NM_004058.5 | c.160G>A | p.Gly54Arg | missense_variant | 3/5 | ENST00000588776.8 | NP_004049.3 | |
CAPS | NM_080590.4 | c.160G>A | p.Gly54Arg | missense_variant | 3/5 | NP_542157.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CAPS | ENST00000588776.8 | c.160G>A | p.Gly54Arg | missense_variant | 3/5 | 1 | NM_004058.5 | ENSP00000465883.2 | ||
ENSG00000267314 | ENST00000588891.1 | n.*255G>A | non_coding_transcript_exon_variant | 4/4 | 4 | ENSP00000468419.1 | ||||
ENSG00000267314 | ENST00000588891.1 | n.*255G>A | 3_prime_UTR_variant | 4/4 | 4 | ENSP00000468419.1 |
Frequencies
GnomAD3 genomes AF: 0.00154 AC: 234AN: 152236Hom.: 2 Cov.: 33
GnomAD3 genomes
AF:
AC:
234
AN:
152236
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00311 AC: 780AN: 250698Hom.: 12 AF XY: 0.00412 AC XY: 559AN XY: 135658
GnomAD3 exomes
AF:
AC:
780
AN:
250698
Hom.:
AF XY:
AC XY:
559
AN XY:
135658
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00149 AC: 2180AN: 1461660Hom.: 38 Cov.: 33 AF XY: 0.00204 AC XY: 1485AN XY: 727146
GnomAD4 exome
AF:
AC:
2180
AN:
1461660
Hom.:
Cov.:
33
AF XY:
AC XY:
1485
AN XY:
727146
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00156 AC: 237AN: 152354Hom.: 2 Cov.: 33 AF XY: 0.00187 AC XY: 139AN XY: 74500
GnomAD4 genome
AF:
AC:
237
AN:
152354
Hom.:
Cov.:
33
AF XY:
AC XY:
139
AN XY:
74500
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
1
ExAC
AF:
AC:
421
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
CAPS-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 17, 2020 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Pathogenic
DEOGEN2
Benign
.;.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T
MetaRNN
Benign
T;T;T
MetaSVM
Uncertain
D
PrimateAI
Uncertain
T
REVEL
Pathogenic
Sift4G
Uncertain
D;D;D
Vest4
MutPred
0.67
.;.;Gain of solvent accessibility (P = 0.0471);
MVP
ClinPred
T
GERP RS
Varity_R
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at